FDAnews
www.fdanews.com/articles/108711-macrogenics-buys-california-based-raven-biotechnologies

MacroGenics Buys California-Based Raven Biotechnologies

July 18, 2008
MacroGenics has acquired Raven Biotechnologies Inc., a South San Francisco, Calif., cancer stem cell company, in an all-stock transaction. The deal, whose terms weren’t disclosed, widens the Rockville company’s cancer-fighting capabilities, nine months after it had licensed its key drug candidate and what many considered its cash cow, a Type I diabetes treatment, to Eli Lilly & Co.
Washington Business Journal